By SIRION Biotech…
Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors
SIRION provides a 360° solution from early R&D up to the late preclinical AAV vector space to develop safe and efficacious AAV-based drug products. Please click on the brochure below to learn more: